StockDrifts LogoStockDrifts

CYBIN INC. · CYBN · 6-K · Filed

CEO Michael Halstead to Participate in Cantor Global Healthcare Conference Fireside Chat

CYBN
6-K
Other filings

Source: SEC EDGAR, accession 0001833141-26-000070

What did CYBIN INC. announce?

Helus Pharma CEO Michael Halstead will participate in a fireside chat at the Cantor Global Healthcare Conference on September 11, 2026.

Key details

  • CEO Michael Halstead will speak at 8:00 a.m. EDT.
  • The fireside chat will be webcast live and a replay will be available on the company's investor relations website.

Why it matters

This 6-K reports a corporate disclosure at CYBIN INC.. The likely share-price reaction reads as neutral.

Neutral

More from CYBIN INC.

All CYBIN INC. SEC filings →